Traded Jul 8, 2026 · Filed Jul 10, 2026
Medtronic's SVP, Chief HR Officer sold $258K of Medtronic shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$257,931
Shares × reported transaction price
35 days after results of Jun 3, 2026, 55 days before results of Sep 1, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $82.01 on Jul 8, 2026, 11% above its 52-week low and 22% below its high, after a 4% rise over the previous 30 trading days
52-week range $73.75 (Jun 2, 2026) to $105.35 (Nov 25, 2025), 26% of the way up, from 251 adjusted closes. 30 trading days earlier: $78.60 on May 22, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.8% | -1.5% | +0.7% |
| 30 days | +6.6% | +2.4% | +4.2% |
Past results only. Not a forecast.
5 different filers disclosed MDT within 90 days. Disclosed 455 days after the transaction; reported as an official range, not an exact amount.
Held by the filer's joint per the disclosure. Disclosed 709 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
Congress trade
Congress trade
